Atezolizumab with carboplatin or cisplatin and pemetrexed for untreated advanced non-squamous non-small-cell lung cancer [ID1495]
Discontinued
Reference number: GID-TA10395
On receiving updated regulatory timing information from the company that markets the technology, NICE has agreed that scoping the topic at this time would not be appropriate. Consequently the consultation on the draft scope will not continue. The consultation will be rescheduled to take place in line with anticipated regulatory approval timings. We apologise for any inconvenience this may cause.
If you have any comments or concerns please contact the project manager for this proposed appraisal Emily Richards on (44 (0)161 413 4070 or via email on emily.richards@nice.org.uk